{"name":"Isoniazid","slug":"isoniazid","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Isonicotinic acid hydrazide","Isonicotinohydrazide","Isoniazide","Rimifon","Cotinazin","Dinacrin","Hydrazid","Nydrazid","Iscotin","Mybasan"],"brands":[],"scraped":true,"has_structure":true,"cid":3767,"classes":[{"name":"antibiotic","href":"/class/antibiotic"}],"families":[],"physical":[{"label":"Molecular mass","value":"137.14 g/mol","copyable":false},{"label":"Appearance","value":"COLORLESS OR WHITE CRYSTALS, OR A WHITE, CRYSTALLINE POWDER","copyable":false},{"label":"Melting point","value":"340.5 °F (NTP, 1992)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitrogen oxides/.","copyable":false},{"label":"Solubility","value":"greater than or equal to 100 mg/mL at 77 °F (NTP, 1992)","copyable":false},{"label":"Predicted LogP","value":"-0.7","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>6</sub>H<sub>7</sub>N<sub>3</sub>O","copyable":true},{"label":"IUPAC name","value":"pyridine-4-carbohydrazide","copyable":true},{"label":"SMILES","value":"C1=CN=CC=C1C(=O)NN","copyable":true},{"label":"InChI","value":"InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)","copyable":true},{"label":"InChIKey","value":"QRXWMOHMRWLFEY-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"54-85-3","copyable":true},{"label":"UNII","value":"V83O1VOZ8L","copyable":true},{"label":"PubChem CID","value":"3767","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"0.5–1.6h (fast acetylators), 2-5h (slow acetylators)","copyable":false},{"label":"Metabolism","value":"liver; CYP450: 2C19, 3A4 inhibitor","copyable":false},{"label":"Excretion","value":"urine (primarily), feces","copyable":false},{"label":"Routes of administration","value":"By mouth, intramuscular, intravenous","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"ip","dose":"100 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"650 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"J","description":"Antiinfectives for systemic use"},{"code":"J04","description":"Antimycobacterials"},{"code":"J04A","description":"Drugs for treatment of tuberculosis"},{"code":"J04AC","description":"Hydrazides"},{"code":"J04AC01","description":""},{"code":"J04AC01","description":"Isoniazid"}],"mesh":[{"name":"Antitubercular Agents","id":"M0001515"},{"name":"Fatty Acid Synthesis Inhibitors","id":"M0508507"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Isoniazid is a prodrug and must be activated by bacterial catalase. Specficially, activation is associated with reduction of the mycobacterial ferric KatG catalase-peroxidase by hydrazine and reaction with oxygen to form an oxyferrous enzyme complex. Once activated, isoniazid inhibits the synthesis of mycoloic acids, an essential component of the bacterial cell wall. At therapeutic levels isoniazid is bacteriocidal against actively growing intracellular and extracellular <i>Mycobacterium tuberculosis</i> organisms. Specifically isoniazid inhibits InhA, the enoyl reductase from <i>Mycobacterium tuberculosis</i>, by forming a covalent adduct with the NAD cofactor. It is the INH-NAD adduct that acts as a slow, tight-binding competitive inhibitor of InhA.","side_effects":{"drug_id":3767,"drug_name":"isoniazid","url":"https://sideeffects.embl.de/drugs/3767/pt","atc_codes":["J04AC01"],"side_effects":[{"name":"Agranulocytosis","cui":"C0001824"},{"name":"Aplastic anaemia","cui":"C0002874"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Eosinophilia","cui":"C0014457"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Gynaecomastia","cui":"C0018418"},{"name":"Hepatitis","cui":"C0019158"},{"name":"Hepatitis symptom","cui":"C0858814"},{"name":"Hyperbilirubinaemia","cui":"C0020433"},{"name":"Hyperglycaemia","cui":"C0020456"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Jaundice","cui":"C0022346"},{"name":"Systemic lupus erythematosus","cui":"C0024141"},{"name":"Malaise","cui":"C0231218"},{"name":"Nausea","cui":"C0027497"},{"name":"Neuritis","cui":"C0027813"},{"name":"Neuropathy peripheral","cui":"C0031117"},{"name":"Optic neuritis","cui":"C0029134"},{"name":"Nicotinic acid deficiency","cui":"C0030783"},{"name":"Psychotic disorder","cui":"C0033975"},{"name":"Convulsion","cui":"C0036572"},{"name":"Thrombocytopenia","cui":"C0040034"},{"name":"Vasculitis","cui":"C0042384"},{"name":"Vomiting","cui":"C0042963"},{"name":"Hepatic function abnormal","cui":"C0086565"},{"name":"Toxic encephalopathy","cui":"C0149504"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Liver injury","cui":"C0160390"},{"name":"Metabolic acidosis","cui":"C0220981"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Discomfort","cui":"C0234215"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Ill-defined disorder","cui":"C2047937"},{"name":"Emotional distress","cui":"C0700361"},{"name":"Memory impairment","cui":"C0233794"},{"name":"Neurotoxicity","cui":"C0235032"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Diabetes mellitus","cui":"C0011849"},{"name":"Rash","cui":"C0015230"},{"name":"Atrophy","cui":"C0333641"},{"name":"Lymphadenopathy","cui":"C0497156"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Vitamin B6 deficiency","cui":"C0936215"}],"indications":[{"name":"Active tuberculosis","cui":"C0151332"},{"name":"Carcinoma","cui":"C0007097"},{"name":"Chronic peptic ulcer","cui":"C0700509"},{"name":"Diabetes mellitus","cui":"C0011849"},{"name":"Extrapulmonary tuberculosis","cui":"C0679362"},{"name":"Hodgkin's disease","cui":"C0019829"},{"name":"Immunodeficiency","cui":"C0021051"},{"name":"Induration","cui":"C0332534"},{"name":"Infection","cui":"C0009450"},{"name":"Leukaemia","cui":"C0023418"},{"name":"Low income","cui":"C1331016"},{"name":"Malabsorption","cui":"C0024523"},{"name":"Malnutrition","cui":"C0162429"},{"name":"Renal failure chronic","cui":"C0022661"},{"name":"Silicosis","cui":"C0037116"},{"name":"Skin test reaction","cui":"C0312646"},{"name":"Tuberculosis","cui":"C0041296"},{"name":"Ulcer","cui":"C0041582"},{"name":"Weight decreased","cui":"C0043096"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[3]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Isoniazid"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/3767"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q423169"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00951"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL64"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A6030"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=54-85-3"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015086"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07054"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8020755"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Isoniazid"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/V83O1VOZ8L"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/3767/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 3767, Isoniazid. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/3767>https://pubchem.ncbi.nlm.nih.gov/compound/3767</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Isoniazid. UNII: V83O1VOZ8L. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/V83O1VOZ8L>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/V83O1VOZ8L</a>","Drug and medical device highlights 2018: Helping you maintain and improve your health. Health Canada. 14 October 2020. <a href='https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/drug-medical-device-highlights-2018.html'>https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/drug-medical-device-highlights-2018.html</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 16:02:27","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 16:02:23","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 16:02:23","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 16:02:24","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 16:02:23","note":"hmdb.ca refused automated access to HMDB0015086"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 16:02:26","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 16:02:23","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 16:02:23","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 16:02:24","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 16:02:23","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 16:02:24","note":null}],"description":"Isoniazid is a antibiotic substance."}